Vaccination With Autologous Dendritic Cells Pulsed With Tumor Lysate for Treatment of Patients With Malignant Pleural Mesothelioma.
Phase of Trial: Phase I
Latest Information Update: 24 May 2016
At a glance
- Drugs Dendritic cell vaccine-Amphera (Primary)
- Indications Mesothelioma
- Focus Adverse reactions
- Acronyms DC-immunotherapy
- 20 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2009 Planned end date changed from 31 Dec 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 25 Aug 2006 New trial record.